Georgia's Online Cancer Information Center

Find A Treatment Site

Phoebe Cancer Center at Phoebe Putney Memorial Hospital

The Phoebe Cancer Center at Phoebe Putney Memorial Hospital is located in Albany, Georgia. The center is fully accredited by the American College of Surgeons Commission on Cancer as a Community Hospital Comprehensive Cancer Program. The center is also accredited by the American College of Radiology (ACR). There are eleven physicians practicing at the Phoebe Cancer Center, including the following specialties: hematology oncology, radiation oncology and surgical oncology. Services offered include: counseling, support groups, nutrition, oncology wellness program, lymphedema clinic, breast cancer nurse navigator, transportation options, light house, inpatient unit, pastoral care, hospice, financial assistance, Carlton Breast Health Center and tumor registry. Each patient at the Phoebe Cancer Center has an entire team working for them, including doctors, certified oncology nurses, pharmacists, lab analysts, counselors and other medical professionals. The center is also a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers.

Treatment Sites in Georgia

Clinical Trials in Georgia

A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients
Cancer Type: Lung Cancer, Unknown Primary

Additional Support Program via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
Cancer Type: Breast Cancer

Biomarker-Driven Therapy and Immunotherapy in Screening Participants with Recurrent or Stage IV Non-Small Cell Lung Cancer (The Expanded Lung-MAP Screening Trial)
Cancer Type: Lung Cancer

Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients with Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study
Cancer Type: Colon/Rectal Cancer, Unknown Primary

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer, Unknown Primary

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Cancer Type: Solid Tumor

Implementation and Effectiveness of HN-STAR in Managing the Health of Head and Neck Squamous Cell Cancer Survivors
Cancer Type: Head and Neck Cancer

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Cancer Type: Breast Cancer, Unknown Primary

Mobile Health for Adherence in Breast Cancer Patients
Cancer Type: Breast Cancer

Pembrolizumab versus Observation in Patients with Early Stage Triple-Negative Breast Cancer who had a Pathologic Complete Response after Chemotherapy plus Pembrolizumab, OptimICE-PCR Trial
Cancer Type: Breast Cancer, Unknown Primary

T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Cancer Type: Breast Cancer

Testing the Use of the Usual Chemotherapy before and after Surgery for Removable Pancreatic Cancer
Cancer Type: Pancreatic Cancer

Using Cancer Cells in the Blood (ctDNA) to Determine the Type of Chemotherapy that will Benefit Patients who Have Had Surgery for Colon Cancer, (CIRCULATE-NORTH AMERICA)
Cancer Type: Colon/Rectal Cancer, Unknown Primary
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.